Published in Circulation on March 01, 1992
Contemporary criteria for the selection of patients for percutaneous balloon mitral valvuloplasty. Heart (2002) 1.01
Predictors of persistent pulmonary hypertension after mitral valve replacement. Heart Vessels (2015) 0.84
Coronary artery disease, valvular heart disease, bradycardia, and heart failure. Postgrad Med J (1995) 0.84
Transoesophageal echocardiographic assessment of mitral valve commissural morphology predicts outcome after balloon mitral valvotomy. Heart (2006) 0.80
Mitral annular calcification predicts immediate results of percutaneous transvenous mitral commissurotomy. Cardiovasc Ultrasound (2011) 0.78
Balloon valvuloplasty. Heart (2001) 0.76
Clinical and echocardiographic characteristics of papillary fibroelastomas: a retrospective and prospective study in 162 patients. Circulation (2001) 4.85
Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J (1988) 4.01
Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med (1998) 3.81
Percutaneous balloon pericardial window for patients with malignant pericardial effusion and tamponade. Cathet Cardiovasc Diagn (1991) 3.17
Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation (1995) 2.97
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation (1994) 2.77
Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation (1997) 2.65
Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation (2000) 2.65
Unusual sequelae after percutaneous mitral valvuloplasty: a Doppler echocardiographic study. J Am Coll Cardiol (1992) 2.63
Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation (1983) 2.59
Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol (1982) 2.54
Intraaortic balloon pumping for cardiac support: trends in practice and outcome, 1968 to 1995. J Thorac Cardiovasc Surg (1997) 2.27
Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation (2001) 2.17
Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. Circulation (1997) 2.15
Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med (1993) 2.14
Mechanisms of hemolysis with mitral prosthetic regurgitation. Study using transesophageal echocardiography and fluid dynamic simulation. J Am Coll Cardiol (1996) 2.14
Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med (1982) 2.09
Transcatheter closure of ventricular septal defects. Circulation (1988) 2.05
Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med (1985) 1.99
Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation (1994) 1.95
Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: impact of 14 new sequences from IgG myeloma proteins. Mol Immunol (1982) 1.93
Platypnea-orthodeoxia: management by transcatheter buttoned device implantation. Catheter Cardiovasc Interv (2001) 1.88
Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation (1997) 1.83
The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis. J Am Coll Cardiol (1994) 1.72
Prediction of successful outcome in 130 patients undergoing percutaneous balloon mitral valvotomy. Circulation (1990) 1.71
Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation (2000) 1.70
Morphology after transluminal angioplasty in human beings. N Engl J Med (1981) 1.69
Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol (1991) 1.67
Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol (1988) 1.65
Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group. J Am Coll Cardiol (1993) 1.65
Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med (1989) 1.62
Differentiation of constrictive pericarditis from restrictive cardiomyopathy: assessment of left ventricular diastolic velocities in longitudinal axis by Doppler tissue imaging. J Am Coll Cardiol (1996) 1.61
Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. J Nucl Cardiol (1997) 1.58
Sex differences in cardiac arrest survivors. Circulation (1996) 1.57
Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris. J Am Coll Cardiol (1993) 1.51
Learning curve of the Inoue technique of percutaneous mitral balloon valvuloplasty. Am J Cardiol (2001) 1.49
Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers. J Nucl Med (1991) 1.45
Quantitation of acute myocardial infarct size by nuclear magnetic resonance imaging. J Am Coll Cardiol (1990) 1.43
Risk predictors in patients scheduled for percutaneous coronary revascularization. Catheter Cardiovasc Interv (1999) 1.43
Percutaneous mitral balloon valvotomy. N Engl J Med (1992) 1.42
Continuous quality improvement decreases length of stay and adverse events: a case study in an interventional cardiology program. Am J Manag Care (1997) 1.41
Current medical management of valvular heart disease. Cleve Clin J Med (2001) 1.40
Assessment of mitral annular dynamics during diastole by Doppler tissue imaging: comparison with mitral Doppler inflow in subjects without heart disease and in patients with left ventricular hypertrophy. Am Heart J (1996) 1.39
Percutaneous balloon valvotomy for patients with severe mitral stenosis. Circulation (1987) 1.37
Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci U S A (1996) 1.37
Improved results of surgical management of postinfarction ventricular septal rupture. Ann Surg (1982) 1.37
Left ventricular function after valve repair for chronic mitral regurgitation: predictive value of preoperative assessment of contractile reserve by exercise echocardiography. J Am Coll Cardiol (1996) 1.34
Percutaneous transvenous balloon valvotomy in a patient with severe calcific mitral stenosis. J Am Coll Cardiol (1986) 1.28
The technique and safety of transseptal left heart catheterization: the Massachusetts General Hospital experience with 1,279 procedures. Cathet Cardiovasc Diagn (1994) 1.26
Percutaneous balloon pericardiotomy for the treatment of cardiac tamponade and large pericardial effusions: description of technique and report of the first 50 cases. J Am Coll Cardiol (1993) 1.22
Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol (1983) 1.22
Effects of anesthetic technique on myocardial wall motion abnormalities during abdominal aortic surgery. J Cardiothorac Vasc Anesth (1997) 1.22
Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities. Neurosurgery (1999) 1.20
Stroke as a complication of cardiac catheterization: risk factors and clinical features. Neurology (2001) 1.20
Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenoses and relationship to regional wall motion. Circulation (1982) 1.19
Myocardial wall velocity assessment by pulsed Doppler tissue imaging: characteristic findings in normal subjects. Am Heart J (1996) 1.18
The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol (1997) 1.18
Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation (1996) 1.18
Murine model of accelerated transplant arteriosclerosis. Circ Res (1994) 1.18
Prosthetic valve endocarditis. J Thorac Cardiovasc Surg (1970) 1.16
Detection of left atrial myxoma by gated radionuclide cardiac imaging. Circulation (1977) 1.16
Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol (2000) 1.15
Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J (1994) 1.15
Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med (1987) 1.13
Caseous calcification of the mitral annulus: an underappreciated variant. Heart (2004) 1.12
Follow-up of patients undergoing percutaneous mitral balloon valvotomy. Analysis of factors determining restenosis. Circulation (1989) 1.11
Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis. Circulation (1995) 1.11
Echocardiographic evaluation of mitral valve structure and function in patients followed for at least 6 months after percutaneous balloon mitral valvuloplasty. J Am Coll Cardiol (1988) 1.10
Percutaneous mitral balloon valvotomy during pregnancy in a patient with severe mitral stenosis. Cathet Cardiovasc Diagn (1988) 1.10
Improvement in mitral regurgitation after aortic valve replacement. Am J Cardiol (1997) 1.09
Transluminal angioplasty: correlation of morphologic and angiographic findings in an experimental model. Circulation (1980) 1.09
Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation (1996) 1.08
Scanning electron microscopy after coronary transluminal angioplasty of normal canine coronary arteries. Am J Cardiol (1980) 1.07
Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI). J Am Coll Cardiol (1996) 1.07
Thromboxane release during percutaneous transluminal coronary angioplasty. Am Heart J (1986) 1.06
Inaccuracy of mitral pressure half-time immediately after percutaneous mitral valvotomy. Dependence on transmitral gradient and left atrial and ventricular compliance. Circulation (1988) 1.05
Coexistent fixed congenital and idiopathic hypertrophic subaortic stenosis. Am J Cardiol (1973) 1.05
Calculation of mitral regurgitant orifice area with use of a simplified proximal convergence method: initial clinical application. J Am Soc Echocardiogr (2001) 1.05
Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization. J Am Coll Cardiol (1999) 1.05
Prevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantation. J Am Coll Cardiol (1995) 1.05
Transluminal coronary angioplasty of postmortem human hearts. Am J Cardiol (1981) 1.05
Echocardiography can predict which patients will develop severe mitral regurgitation after percutaneous mitral valvulotomy. J Am Coll Cardiol (1996) 1.04
Regional myocardial perfusion after experimental subarachnoid hemorrhage. Stroke (2000) 1.03
Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation (2000) 1.02
Experimental angioplasty: lessons from the laboratory. AJR Am J Roentgenol (1980) 1.02